Why medical cannabis should be covered by plans and payers

With cannabinoid-based medicines, clinicians can often wean multiple other meds - which not only has a powerful effect on patients' well-being - but also a huge cost-saving effect. I'll be publishing some data on this soon - but if any of you have further evidence to illustrate this, please reach out. We'd love to get more people involved in the #CoverCannabis Project. Once the provinces & payers understand the cost-benefit, hopefully there will be more coverage for medical cannabis - especially for our most vulnerable patients. Check out more of my thoughts on this in this article.

Continuing the Conversation: Medical Cannabis in Long-Term Care

I wanted to continue the conversation about cannabinoid therapy in long term care this week by sharing some insights from my colleague Kim Van Dam, Administrator at Steeves & Rozema’s Trillium Villa. 

Here she talks about the outcomes we’ve seen in successfully reducing narcotic and antipsychotic use amongst residents living with chronic pain and dementia.

Trillium Villa is one of Ontario’s first LTC residences to introduce cannabinoid therapy and the first home that I worked in several years ago. I continue to work with Kim and the forward-thinking & dedicated S&R team to this day and have been excited by the number of like-minded long term care organizations and in-house physicians who have reached out to learn more about whether it could benefit their residents/patients.